Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.52 |
| ▸ | RARB | P10826 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5086980 | 1.00 | PLA2G2A (0.73) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL11695455 | 1.00 | PLA2G2A (0.73) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| Hydrochloric Acid SCHEMBL5005668 | 0.98 | PLA2G2A (0.71) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL17414620 | 0.93 | PLA2G2A (0.62) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL9168399 | 0.91 | PLA2G2A (0.60) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL203212 | 0.91 | PLA2G2A (0.60) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL15977059 | 0.89 | PLA2G2A (0.57) | PLA2G2ATP53TSHRPLA2G4BNPC1 | |
| SCHEMBL201440 | 0.89 | PLA2G2A (0.59) | PLA2G2ABLMTP53TSHRPLA2G4B | |
| SCHEMBL6836738 | 0.87 | PLA2G2A (0.54) | PLA2G2ATSHRLMNAMAPTHSD17B10 | |
| SCHEMBL25327655 | 0.84 | PLA2G2A (1.00) | PLA2G2ABLMTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8759104-B2 | Cationic lipids | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2014-06-24 | — | — | US | disclosed |
| US-20130065308-A1 | CATIONIC LIPIDS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065308-A1 | CATIONIC LIPIDS | PLIN5, LPCAT3, IPO5 | PLA2G2A 128/4885BLM 3339/4885TP53 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.